Table 1 Correlation between ACER1 expression and clinical prognosis with different clinicopathology in HNSC via KM plotter.

Female

164

0.51 (0.31–0.85)

0.008

94

0.50 (0.16–1.56)

0.22

Male

445

0.59 (0.42–0.82)

0.0016

94

2.37 (0.81–6.91)

0.10

Race

White

526

0.62 (0.45–0.84)

0.0022

133

1.74 (0.76–3.99)

0.18

Asian

11

-

-

4

-

-

Black-African America

74

0.25 (0.10–0.63)

0.0016

5

-

-

Stage

1

50

0.00 (0.00 - lnf)

0.19

66

2.29 (0.28–19.06)

0.43

2

91

1.56 (0.69–3.49)

0.28

57

11.99 (1.38–104.05)

0.0046

3

98

0.58 (0.27–1.22)

0.15

49

0.19 (0.02–1.52)

0.082

4

308

0.59 (0.41–0.85)

0.0037

0

-

-

Grade

1

84

0.44 (0.17–1.09)

0.069

36

− (0.00 - lnf)

0.19

2

340

0.68 (0.47–0.98)

0.037

78

0.47 (0.16–1.35)

0.15

3

158

0.50 (0.29–0.85)

0.0095

49

7.52 (0.9–62.64)

0.028

4

7

-

-

1

-

-

Mutation burden

High

307

0.57 (0.38–0.85)

0.0046

99

3.21 (0.4–25.94)

0.25

Low

296

0.55 (0.36–0.84)

0.0047

89

1.78 (0.69–4.57)

0.23